Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 May;31(5):499-501.
doi: 10.1111/j.1524-4725.2005.31150.

Role of intralesional bleomycin in the treatment of complicated hemangiomas: prospective clinical study

Shapour Omidvari  1 , Nosrat Nezakatgoo, Niloofar Ahmadloo, Mohammad Mohammadianpanah, Ahmad Mosalaei
Affiliations
Clinical Trial

Role of intralesional bleomycin in the treatment of complicated hemangiomas: prospective clinical study

Shapour Omidvari et al. Dermatol Surg. 2005 May.

Abstract

Background: Hemangioma is the most common tumor of infancy. Although it has a basically benign nature and usually spontaneously regresses, a small percentage (5%) have complications that need treatment. Many different therapeutic modalities can be used in this tumor.

Objective: To investigate the effect of a new method of treatment (intralesional bleomycin injection) in complicated hemangiomas.

Materials and methods: In the Department of Radiation Oncology at Nemazee Hospital in Shiraz, Iran, from April 1992 to October 1998, 32 patients with complicated hemangioma were treated with four to six courses of direct injection of bleomycin into the lesion.

Results: After a minimum follow-up of 6 years, there was 70 to 100% regression in 18 patients, 50 to 70% in 7 cases, and less than 50% reduction in 7 patients.

Conclusion: Intralesional injection of bleomycin is an easy, safe, and effective therapeutic modality in complicated cutaneous hemangiomas.

PubMed Disclaimer

Publication types